Answers are grounded in this paper and cite their sources.
Context and objective. Due to the ototoxic effects of aminoglycosides (AGs), bédaquiline-based regimen has been adopted for treatment of Multidrug-resistant tuberculosis (MDR-TB). However, there is limited data regarding the potential of bédaquiline (BDQ) to cause hearing loss. Therefore, the present study aimed to compare the incidence of hearing loss between patients treated with an AG-based regimen and those receiving a BDQ-based regimen. Methods. This multicenter prospective observational cohort study involving patients with MDR-TB, was performed in Kinshasa, from February 15, 2020 to February 14, 2021. Repeated-measure analysis of variance was used to compare changes in the degree of hearing loss over time between two patient groups: those receiving AGs and those on BDQ regimen. The difference-in-differences analysis was estimated using regression with fixed-effects. Results. In total, 335 patients with MDR-TB were included. The degree of hearing loss was similar between the two groups at the first month [AGs (28 dB) vs. BDQ (30 dB); p = 0.298]. At six months, the mean degree of hearing loss was significantly greater in the AG regimen group [AGs (60.5 dB) vs. BDQ (44 dB); p < 0.001]. The difference-in-differences was significant, with a greater increase in hearing loss in the AGs group (diff-in-diff 18.3; p < 0.001). After adjustment for age and serum albumin, the group receiving the AG-based regimen had a 2-point greater worsening than those with BDQ at the sixth month (diff-in-diff 19.8; p < 0.001). Conclusion. Hearing loss is common with both treatment regimens, but more pronounced with the AG-based regimen. Therefore, BDQ should also be considered for audiometric monitoring in future patients with MDR-TB. Received June 15, 2025 Accepted April 4, 2026 https://dx.doi.org/10.4314/aamed.v19i3.2
No takes yet. Share an insight, caveat, or question.
Mpwate et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: